These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 16087108)

  • 1. Electrocardiographic predictors of Brugada type response during Na channel blockade challenge.
    Hermida JS; Denjoy I; Jarry G; Jandaud S; Bertrand C; Delonca J
    Europace; 2005 Sep; 7(5):447-53. PubMed ID: 16087108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Response to intravenous ajmaline: a retrospective analysis of 677 ajmaline challenges.
    Veltmann C; Wolpert C; Sacher F; Mabo P; Schimpf R; Streitner F; Brade J; Kyndt F; Kuschyk J; Le Marec H; Borggrefe M; Probst V
    Europace; 2009 Oct; 11(10):1345-52. PubMed ID: 19589796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New electrocardiographic criteria for discriminating between Brugada types 2 and 3 patterns and incomplete right bundle branch block.
    Chevallier S; Forclaz A; Tenkorang J; Ahmad Y; Faouzi M; Graf D; Schlaepfer J; Pruvot E
    J Am Coll Cardiol; 2011 Nov; 58(22):2290-8. PubMed ID: 22093505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of intracardiac electrogram with surface electrocardiogram in Brugada syndrome patients.
    Probst V; Sacher F; Derval N; Gourraud JB; Mabo P; Medkour F; Le Marec H; Gill J
    Europace; 2014 Jun; 16(6):908-13. PubMed ID: 24068444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autonomic and antiarrhythmic drug modulation of ST segment elevation in patients with Brugada syndrome.
    Miyazaki T; Mitamura H; Miyoshi S; Soejima K; Aizawa Y; Ogawa S
    J Am Coll Cardiol; 1996 Apr; 27(5):1061-70. PubMed ID: 8609322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and clinical course of the juveniles with Brugada-type ECG in Japanese population.
    Oe H; Takagi M; Tanaka A; Namba M; Nishibori Y; Nishida Y; Kawarabayashi T; Yoshiyama M; Nishimoto M; Tanaka K; Yoshikawa J
    Pacing Clin Electrophysiol; 2005 Jun; 28(6):549-54. PubMed ID: 15955188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cibenzoline induced Brugada ECG pattern.
    Sarkozy A; Caenepeel A; Geelen P; Peytchev P; de Zutter M; Brugada P
    Europace; 2005 Nov; 7(6):537-9. PubMed ID: 16216754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Automated detection of Brugada-type electrocardiogram using diagnostic criteria of the European Society of Cardiology and the American Heart Association.
    Kaneko M; Isobe N; Yamaki T; Okamoto N; Watanabe Y; Iwatsuka T; Sakurai T; Kishi R; Nakazawa K; Miyake F
    J Electrocardiol; 2005 Oct; 38(4 Suppl):96-9. PubMed ID: 16226082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is a drug-challenge test with propafenone adequate to exclude Brugada syndrome?
    Yildiz BS; Gungor H; Gul I; Bilgin M; Zoghi M; Akilli A
    Cardiovasc J Afr; 2013 Mar; 24(2):e4-6. PubMed ID: 23613002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in body surface potential distributions induced by isoproterenol and Na channel blockers in patients with the Brugada syndrome.
    Izumida N; Asano Y; Doi S; Wakimoto H; Fukamizu S; Kimura T; Ueyama T; Sakurada H; Kawano S; Sawanobori T; Hiraoka M
    Int J Cardiol; 2004 Jun; 95(2-3):261-8. PubMed ID: 15193830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective study on spontaneous fluctuations between diagnostic and non-diagnostic ECGs in Brugada syndrome: implications for correct phenotyping and risk stratification.
    Veltmann C; Schimpf R; Echternach C; Eckardt L; Kuschyk J; Streitner F; Spehl S; Borggrefe M; Wolpert C
    Eur Heart J; 2006 Nov; 27(21):2544-52. PubMed ID: 16952922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aborted sudden death in a patient with a structurally normal heart: the Brugada syndrome.
    Scherr D; Brunner G; Kaufmann P; Lercher P; Lueger A; Rotman B; Smolle KH; Stark G; Klein W; Krejs GJ
    Intensive Care Med; 2002 Jun; 28(6):789-92. PubMed ID: 12107687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recording of high V1-V3 precordial leads may be essential to the diagnosis of Brugada syndrome during the ajmaline test.
    Teijeiro R; Garro HA; Acunzo RS; Albino E; Chiale PA
    J Cardiovasc Pharmacol Ther; 2006 Jun; 11(2):153-5. PubMed ID: 16891294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variable electrocardiographic effects of short-term quinidine sulfate administration in Brugada syndrome.
    Watanabe H; Chinushi M; Washizuka T; Sugiura H; Hirono T; Komura S; Hosaka Y; Yamaura M; Tanabe Y; Furushima H; Fujita S; Aizawa Y
    Pacing Clin Electrophysiol; 2005 May; 28(5):372-7. PubMed ID: 15869667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utility of high and standard right precordial leads during ajmaline testing for the diagnosis of Brugada syndrome.
    Govindan M; Batchvarov VN; Raju H; Shanmugam N; Bizrah M; Bastiaenen R; Kiotsekoglou A; Camm J; Behr ER
    Heart; 2010 Dec; 96(23):1904-8. PubMed ID: 20962343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. True right bundle branch block masking the typical ECG in Brugada syndrome.
    Rolf S; Haverkamp W; Eckardt L
    Pacing Clin Electrophysiol; 2005 Mar; 28(3):258-9. PubMed ID: 15733192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenotypic characterization of a large European family with Brugada syndrome displaying a sudden unexpected death syndrome mutation in SCN5A:
    Hong K; Berruezo-Sanchez A; Poungvarin N; Oliva A; Vatta M; Brugada J; Brugada P; Towbin JA; Dumaine R; Piñero-Galvez C; Antzelevitch C; Brugada R
    J Cardiovasc Electrophysiol; 2004 Jan; 15(1):64-9. PubMed ID: 15028074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Results of ajmaline testing in patients with arrhythmogenic right ventricular dysplasia-cardiomyopathy.
    Peters S; Trümmel M; Denecke S; Koehler B
    Int J Cardiol; 2004 Jun; 95(2-3):207-10. PubMed ID: 15193821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Usefulness of ST depression with T-wave inversion in leads V(4) to V(6) for predicting one-year mortality in non-ST-elevation acute coronary syndrome (from the Electrocardiographic Analysis of the Global Use of Strategies to Open Occluded Coronary Arteries IIB Trial).
    Atar S; Fu Y; Wagner GS; Rosanio S; Barbagelata A; Birnbaum Y
    Am J Cardiol; 2007 Apr; 99(7):934-8. PubMed ID: 17398187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Local depolarization abnormalities are the dominant pathophysiologic mechanism for type 1 electrocardiogram in brugada syndrome a study of electrocardiograms, vectorcardiograms, and body surface potential maps during ajmaline provocation.
    Postema PG; van Dessel PF; Kors JA; Linnenbank AC; van Herpen G; Ritsema van Eck HJ; van Geloven N; de Bakker JM; Wilde AA; Tan HL
    J Am Coll Cardiol; 2010 Feb; 55(8):789-97. PubMed ID: 20170818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.